Extracorporeal Membrane Oxygenation Machine (ECMO) Machine Market Report 2025

This Extracorporeal Membrane Oxygenation Machine (ECMO) Machine market report delivers an in-depth analysis of the market’s key characteristics, including size, growth potential, and segmentation. It provides a detailed breakdown of the market across major regions and leading countries, highlighting historical data and future growth projections. The report also examines the competitive landscape, market share insights, emerging trends, and strategic developments shaping the market.

The extracorporeal membrane oxygenation machine (ECMO) machine market size has grown strongly in recent years. It will grow from $1.07 billion in 2024 to $1.16 billion in 2025 at a compound annual growth rate (CAGR) of 8.59%. The growth in the historic period was driven by factors such as an aging population with chronic illnesses, increased government funding for healthcare infrastructure, rising demand for emergency and critical care services, a growing prevalence of lifestyle-related disorders, and expanding healthcare expenditures.

The extracorporeal membrane oxygenation machine (ECMO) machine market size is expected to see strong growth in the next few years. It will grow to $1.59 billion in 2029 at a compound annual growth rate (CAGR) of 8.22%. The forecasted growth is attributed to the rising prevalence of cardiovascular and respiratory diseases, increasing incidences of cardiogenic shock, a growing demand for advanced life-support systems, the expansion of ECMO centers globally, and its growing application in lung transplantation procedures. Key trends anticipated during the forecast period include the integration of artificial intelligence for real-time monitoring, the use of augmented reality in ECMO training, technological advancements in ECMO machines, the development of wireless ECMO systems, and the adoption of digital twin technology for enhanced performance and patient outcomes.

The increasing number of lung transplant procedures is significantly driving the growth of the extracorporeal membrane oxygenation (ECMO) machine market. Lung transplants, a life-saving option for patients with end-stage lung diseases, have become more prevalent due to advancements in surgical techniques, enhanced post-transplant care, and an expanding organ donor pool. ECMO machines play a vital role in the success of lung transplant procedures by providing critical support to patients with severe respiratory failure, ensuring stability while awaiting donor lungs. For example, according to the American Journal of Transplantation in February 2024, the number of lung transplants in the United States increased from 2,569 in 2021 to 2,743 in 2022. This rising demand for lung transplants underscores the growing reliance on ECMO machines, fueling market growth.

Companies in the ECMO machine market are investing in innovative technologies, such as configurable one-system ECMO solutions, to improve patient outcomes and streamline critical care processes. Configurable ECMO machines offer flexibility by tailoring settings and components to individual patient needs, ensuring optimal respiratory and cardiac support. For instance, in September 2024, Medtronic plc launched VitalFlow, a state-of-the-art ECMO solution emphasizing simplicity, adaptability, and high performance. This system supports both venovenous (VV) and venoarterial (VA) configurations, offering advanced monitoring capabilities and ease of use in diverse clinical scenarios, thus enhancing patient care in critical environments.

In March 2024, Medtronic plc acquired MC3 Cardiopulmonary, a leader in ECMO technology development, to strengthen its cardiac surgery and critical care portfolio. This acquisition enables Medtronic to integrate cutting-edge ECMO technologies into its product offerings, providing innovative solutions for patients experiencing severe heart and lung failure. MC3 Cardiopulmonary’s expertise in ECMO system development aligns with Medtronic's vision of advancing life-support solutions, positioning the company as a leader in the rapidly growing ECMO machine market.

Major players in the extracorporeal membrane oxygenation machine (ECMO) machine market are Abiomed Inc., Abbott Laboratories, Medtronic plc, Fresenius Medical Care AG & Co. KGaA, Terumo Cardiovascular Systems Corporation, Shenzhen Mindray Biomedical Electronics Co. Ltd., Nipro Corporation, Getinge Group, LivaNova plc, MicroPort Scientific Corporation, Hamilton Medical AG, Braile Biomédica, Xenios AG, Cytosorbents Corporation, Eurosets S.R.L., MC3 Cardiopulmonary, OriGen Biomedical Inc., Inspira Technologies OXY B.H.N. Ltd., Technimount System, Sorin Group.

North America was the largest region in the extracorporeal membrane oxygenation machine (ECMO) machine market in 2024. The regions covered in extracorporeal membrane oxygenation machine (ECMO) machine report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the extracorporeal membrane oxygenation machine (ECMO) machine market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

An extracorporeal membrane oxygenation (ECMO) machine is a specialized medical device designed to provide cardiac and respiratory support by oxygenating blood outside the body. It is typically used for patients with severe heart or lung failure, offering critical care in life-threatening conditions.

The main components of an ECMO machine include pumps, oxygenators, controllers, cannulas, and accessories. ECMO pumps circulate blood through the oxygenator, ensuring adequate blood flow during respiratory or cardiac failure. These pumps play a vital role in sustaining circulation during ECMO procedures. ECMO modalities consist of veno-venous (VV), veno-arterial (VA), and arterio-venous (AV) configurations, tailored to meet specific clinical needs. Patient types include neonates, pediatrics, and adults, with applications primarily in treating respiratory and cardiac conditions. Key end users of ECMO machines include hospitals, ambulatory surgical centers, and research institutions.

The extracorporeal membrane oxygenation (ECMO) machine market research report is one of a series of new reports that provides extracorporeal membrane oxygenation (ECMO) machine market statistics, including the extracorporeal membrane oxygenation (ECMO) machine industry global market size, regional shares, competitors with the extracorporeal membrane oxygenation (ECMO) machine market share, detailed extracorporeal membrane oxygenation (ECMO) machine market segments, market trends, and opportunities, and any further data you may need to thrive in the extracorporeal membrane oxygenation (ECMO) machine industry. This extracorporeal membrane oxygenation (ECMO) machine market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The extracorporeal membrane oxygenation (ECMO) machine market consists of sales of advanced life-support systems, monitoring systems, blood pumps, and consumables. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.